A phase Ib/II dose expansion study of subcutaneous sasanlimab in patients with locally advanced or metastatic non-small-cell lung cancer and urothelial carcinoma
| Autor: | Cho, B.C., Penkov, K., Bondarenko, I., Kurochkin, A., Pikiel, J., Ahn, H.K., Korożan, M.E., Osipov, M., Odintsova, S., Braiteh, F., Ribas, A., Grilley-Olson, J.E., Lugowska, I., Bonato, V., Damore, M.A., Yang, W., Jacobs, I.A., Bowers, M., Li, M., Johnson, M.L. |
|---|---|
| Zdroj: | In ESMO Open August 2023 8(4) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|